pharma news today obesity glp-1 drugs changed the conversation almost overnight. But the boom created a second market around compounded versions, online sales, and aggressive marketing that patients now have to navigate. According to a Could weight-loss drugs eat the

Qsymia : In a 56-week trial, people lost an average of 10% of their starting weight on the highest dose (15 mg/92 mg)

The SUSTAIN-7 trial was a randomized, open-label, active-controlled, parallel, four-armed trial

GLP-1 injections contain real medications such as semaglutide and tirzepatide

Besides weight loss, GLP-1 medications are shown to lower those health risks

Biosafety Health

However, a decrease in the expression of MCT4 (monocarboxylate transporter 4), GLUT1, GLUT3 and an increase in the concentrations of alanine and acetate were also reported (77) suggesting activation of glycolysis without concomitant increase in mitochondrial bioenergetics